Author:
Scott Andrew J.,Mittal Anjali,Meghdadi Baharan,Palavalasa Sravya,Achreja Abhinav,O’Brien Alexandra,Kothari Ayesha U.,Zhou Weihua,Xu Jie,Lin Angelica,Wilder-Romans Kari,Edwards Donna M.,Wu Zhe,Feng Jiane,Andren Anthony C.,Zhang Li,Tarnal Vijay,Redic Kimberly A.,Qi Nathan,Fischer Joshua,Yang Ethan,Regan Michael S.,Stopka Sylwia A,Baquer Gerard,Lawrence Theodore S.,Venneti Sriram,Agar Nathalie Y. R.,Lyssiotis Costas A.,Al-Holou Wajd N.,Nagrath Deepak,Wahl Daniel R.
Abstract
AbstractThe brain avidly consumes glucose to fuel neurophysiology. Cancers of the brain, such as glioblastoma (GBM), lose aspects of normal biology and gain the ability to proliferate and invade healthy tissue. How brain cancers rewire glucose utilization to fuel these processes is poorly understood. Here we perform infusions of13C-labeled glucose into patients and mice with brain cancer to define the metabolic fates of glucose-derived carbon in tumor and cortex. By combining these measurements with quantitative metabolic flux analysis, we find that human cortex funnels glucose-derived carbons towards physiologic processes including TCA cycle oxidation and neurotransmitter synthesis. In contrast, brain cancers downregulate these physiologic processes, scavenge alternative carbon sources from the environment, and instead use glucose-derived carbons to produce molecules needed for proliferation and invasion. Targeting this metabolic rewiring in mice through dietary modulation selectively alters GBM metabolism and slows tumor growth.SignificanceThis study is the first to directly measure biosynthetic flux in both glioma and cortical tissue in human brain cancer patients. Brain tumors rewire glucose carbon utilization away from oxidation and neurotransmitter production towards biosynthesis to fuel growth. Blocking these metabolic adaptations with dietary interventions slows brain cancer growth with minimal effects on cortical metabolism.
Publisher
Cold Spring Harbor Laboratory